Virafin from Zydus gets emergency nod for treating moderate COVID-19 infections in adults

For the development of Virafin, Zydus appreciated the support provided by DBT-BIRAC COVID 19 Research Consortium through NBM, for conducting the Phase II human clinical trial studies.